news

Haomo Intelligence announced its Series A financing, with investors including Fujian Innovation Investment, Fortune Capital, etc.

2024-08-15

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

According to the information released by Tianyancha APP on August 12, Xiamen Haomo Intelligent Manufacturing Co., Ltd. announced its Series A financing. The amount of financing was not disclosed. The institutions participating in the investment included Fujian Innovation Investment, Fortune Capital, Xiamen Hi-Tech Investment, and Xiamen Emerging Industry Venture Capital.

The historical financing of Xiamen Haomo Intelligent Manufacturing Co., Ltd. is as follows:

Xiamen Haomo Intelligent Manufacturing Co., Ltd. is located in Xiamen, which is known as the "Garden on the Sea". Its subsidiary Xiamen Squirrel Precision Technology Co., Ltd. is a "double hundred" enterprise in Xiamen. The company is talent-oriented and committed to the research and industrialization of the country's "stuck neck" and "short board" technologies. It is mainly engaged in the research, development, manufacturing and sales of high-end CNC machine tools and equipment, ultra-precision optical components, etc. The company's products cover a variety of precision and ultra-precision machine tools and equipment such as five-axis linkage machining centers, ultra-precision surface grinders, CCOS flexible polishing machines, etc. At the same time, the company also has the production capacity of medium and large-caliber ultra-precision optical components with a variety of materials and surface shapes.

Data source: Tianyancha APP

The above content is compiled by Securities Star based on public information and generated by algorithms (Net Information Computing No. 310104345710301240019), which has nothing to do with the position of this website. If there are any problems with the data, please contact us. This article is a data compilation and does not constitute any investment advice to you. Investment is risky, please make decisions with caution.